AdvisorShares Psychedelics ETF(PSIL · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $13.40 – $22.49
- YTD
- +16.92%
- IV Rank (30D)
- 35.09
- Straddle Price
- $2.35
- P/C Vol Ratio
- 0.59
AdvisorShares Psychedelics ETF (PSIL) ETF
- Exchange
- ARCX
- Inception
- 2021-09-15
- Has Options
- Yes
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2025-12-22 | 2025-12-29 | $1.6839 | CD |
| 2025-09-22 | 2025-09-29 | $0.0201 | CD |
| 2025-06-23 | 2025-06-27 | $0.0119 | CD |
| 2025-03-21 | 2025-03-28 | $0.1634 | CD |
| 2024-12-23 | 2024-12-30 | $0.0548 | CD |
| 2024-09-23 | 2024-09-30 | $0.1087 | CD |
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| — | DREY INST PREF GOV MM-M | 17.77% | Short-term investment | US |
| VALU | Atai Beckley NV | 12.14% | Equity (common) | NL |
| CMPS | Compass Pathways Plc | 8.62% | Equity (common) | GB |
| RLMD | Relmada Therapeutics Inc | 8.35% | Equity (common) | US |
| SUPN | Supernus Pharmaceuticals Inc | 7.64% | Equity (common) | US |
| DFTX | Mind Medicine MindMed Inc | 7.45% | Equity (common) | US |
| NRXP | NRX Therapeutics Inc | 4.81% | Equity (common) | US |
| VALU | Alkermes PLC | 4.63% | Equity (common) | IE |
| VALU | GH Research PLC | 4.61% | Equity (common) | IE |
| NBIX | Neurocrine Biosciences Inc | 4.53% | Equity (common) | US |
| HELP | Cybin Inc | 4.34% | Equity (common) | CA |
| ANRO | Alto Neuroscience Inc | 4.25% | Equity (common) | US |
| DRUG | Bright Minds Biosciences Inc | 4.20% | Equity (common) | US |
| — | BLACKROCK TREASURY TRUST | 4.09% | Short-term investment | US |
| ABBV | AbbVie Inc | 3.64% | Equity (common) | US |
| JNJ | Johnson & Johnson | 3.42% | Equity (common) | US |
| NEUP | Neuphoria Therapeutics Inc | 2.82% | Equity (common) | US |
| KTTA | Pasithea Therapeutics Corp | 2.13% | Equity (common) | US |
| STIM | Neuronetics Inc | 2.02% | Equity (common) | US |
| QNTM | Quantum BioPharma Ltd | 1.96% | Equity (common) | CA |
| — | Incannex Healthcare Inc | 1.29% | Equity (common) | AU |
| SILO | Silo Pharma Inc | 1.10% | Equity (common) | US |
| VTGN | Vistagen Therapeutics Inc | 0.90% | Equity (common) | US |
| NUMIF | Numinus Wellness Inc | 0.79% | Equity (common) | CA |
| ENVB | Enveric Biosciences Inc | 0.33% | Equity (common) | US |
| CMND | Clearmind Medicine Inc | 0.07% | Equity (common) | CA |
| VALU | QUANTUM BIOPHARMA | 0.00% | Equity (common) | CA |
| VALU | SAGE THERAPEUTICS INC | 0.00% | Equity (common) | US |
| VALU | UNBUZZD WELLNESS INC | 0.00% | Equity (common) | CA |
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | Atai Beckley NV | Atai Beckley NV | 12.14% | $2.2M |
| 2 | Compass Pathways Plc | Compass Pathways Plc | 8.62% | $1.6M |
| 3 | Relmada Therapeutics Inc | Relmada Therapeutics Inc | 8.35% | $1.5M |
| 4 | Supernus Pharmaceuticals Inc | Supernus Pharmaceuticals Inc | 7.64% | $1.4M |
| 5 | Mind Medicine MindMed Inc | Mind Medicine MindMed Inc | 7.45% | $1.4M |
| 6 | NRX Therapeutics Inc | NRX Therapeutics Inc | 4.81% | $888891 |
| 7 | Alkermes PLC | Alkermes PLC | 4.63% | $855628 |
| 8 | GH Research PLC | GH Research PLC | 4.61% | $852322 |
| 9 | Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | 4.53% | $836939 |
| 10 | Cybin Inc | Cybin Inc | 4.34% | $802114 |
| 11 | Alto Neuroscience Inc | Alto Neuroscience Inc | 4.25% | $784571 |
| 12 | Bright Minds Biosciences Inc | Bright Minds Biosciences Inc | 4.20% | $776030 |
| 13 | AbbVie Inc | AbbVie Inc | 3.64% | $672446 |
| 14 | Johnson & Johnson | Johnson & Johnson | 3.42% | $632439 |
| 15 | Neuphoria Therapeutics Inc | Neuphoria Therapeutics Inc | 2.82% | $520673 |
| 16 | Pasithea Therapeutics Corp | Pasithea Therapeutics Corp | 2.13% | $393090 |
| 17 | Neuronetics Inc | Neuronetics Inc | 2.02% | $373864 |
| 18 | Quantum BioPharma Ltd | Quantum BioPharma Ltd | 1.96% | $362321 |
| 19 | Incannex Healthcare Inc | Incannex Healthcare Inc | 1.29% | $237614 |
| 20 | Silo Pharma Inc | Silo Pharma Inc | 1.10% | $203832 |
| 21 | Vistagen Therapeutics Inc | Vistagen Therapeutics Inc | 0.90% | $165599 |
| 22 | Numinus Wellness Inc | Numinus Wellness Inc | 0.79% | $145173 |
| 23 | Enveric Biosciences Inc | Enveric Biosciences Inc | 0.33% | $61616 |
| 24 | Clearmind Medicine Inc | Clearmind Medicine Inc | 0.06% | $12004 |
| 25 | QUANTUM BIOPHARMA | QUANTUM BIOPHARMA | 0.00% | — |
| Category | Weight | Value | Positions |
|---|---|---|---|
| Short-term investment | 21.86% | $4.0M | 2 |
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +1.08% | 5 |
| Feb | -2.97% | 5 |
| Mar | -5.28% | 5 |
| Apr | -7.35% | 5 |
| May | -0.81% | 5 |
| Jun | -5.38% | 5 |
| Jul | +11.83% | 4 |
| Aug | +1.92% | 4 |
| Sep | -10.28% | 5 |
| Oct | +7.41% | 5 |
| Nov | -8.52% | 5 |
| Dec | -11.90% | 5 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
- IV Rank (30D)
- 35.09
- IV Rank (7D)
- 100
- Avg IV
- 68.8%
- Straddle (30D)
- $2.35
- Straddle (7D)
- $1.67
- P/C Volume
- 0.59
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 1.48
- Correlation (SPY)
- 42.8%
- R²
- 0.18
- Ann. Volatility
- 42.7%
- SPY Volatility
- 12.3%
High volatility - stock moves more than market
Click any bar to view the full quote for that stock.
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|